MAPT and Alzheimer disease: To relate rs148726219 to AD pathogenesis in neuronal function, more extensive functional evaluation of rs148726219 effects should be completed in iNs (for example: more engineered lines tested by MEA and calcium imaging as well as evaluation of pathologic amyloid/tau seeding to connect upregulated circuit function to AD pathology) [46].